Literature DB >> 29788763

Progress toward development of a proteostasis drug for myocilin-associated glaucoma.

Dustin Je Huard1, Raquel L Lieberman1.   

Abstract

Entities:  

Keywords:  Grp94; aggregation; glaucoma; inhibitor; meshwork; myocilin; proteostasis; trabecular

Mesh：

Substances：

Year:  2018        PMID： 29788763     DOI： 10.4155/fmc-2018-0073

Source DB:  PubMed          Journal:  Future Med Chem        ISSN： 1756-8919            Impact factor:   3.808


× No keyword cloud information.
  3 in total

Review 1.  Myocilin-associated Glaucoma: A Historical Perspective and Recent Research Progress.

Authors:  Ritika Sharma; Abhinav Grover
Journal:  Mol Vis       Date:  2021-08-20       Impact factor: 2.367

Review 2.  Physiological function of myocilin and its role in the pathogenesis of glaucoma in the trabecular meshwork (Review).

Authors:  Hongwei Wang; Mingzhe Li; Zhenzhen Zhang; Haifeng Xue; Xing Chen; Yong Ji
Journal:  Int J Mol Med       Date:  2018-11-20       Impact factor: 4.101

3.  Identification of a novel MYOC variant in a Hispanic family with early-onset primary open-angle glaucoma with elevated intraocular pressure.

Authors:  June Criscione; Weizhen Ji; Lauren Jeffries; James M McGrath; Scott Soloway; Lajos Pusztai; Saquib Lakhani
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.